Cargando…
A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine
The COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has spread worldwide, with millions of cases and more than 1 million deaths to date. The gravity of the situation mandates accelerated efforts to identify safe and effective vaccines. Here, we generat...
Autores principales: | Hörner, Cindy, Schürmann, Christoph, Auste, Arne, Ebenig, Aileen, Muraleedharan, Samada, Dinnon, Kenneth H., Scholz, Tatjana, Herrmann, Maike, Schnierle, Barbara S., Baric, Ralph S., Mühlebach, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768780/ https://www.ncbi.nlm.nih.gov/pubmed/33257540 http://dx.doi.org/10.1073/pnas.2014468117 |
Ejemplares similares
-
Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
por: Ebenig, Aileen, et al.
Publicado: (2022) -
Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after T(H)2-biased immunization
por: Ebenig, Aileen, et al.
Publicado: (2022) -
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection
por: Henss, Lisa, et al.
Publicado: (2021) -
Vaccine platform recombinant measles virus
por: Mühlebach, Michael D.
Publicado: (2017) -
Development of Recombinant Measles Virus-Based Vaccines
por: Mühlebach, Michael D., et al.
Publicado: (2016)